AllianceBernstein’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

AllianceBernstein’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-43,400	Closed	-$1.21M	–	3185
2019 Q3	$1.21M	Buy	43,400 +8,300	+24%	+$134K	﹤0.01%	2174
2019 Q2	$495K	Buy	35,100 +5,100	+17%	+$48.5K	﹤0.01%	2605
2019 Q1	$267K	Buy	30,000 +12,800	+74%	+$104K	﹤0.01%	2803
2018 Q4	$130K	Buy	17,200 +5,000	+41%	+$80.5K	﹤0.01%	2966
2018 Q3	$256K	Buy	12,200 +1,600	+15%	+$38.1K	﹤0.01%	2908
2018 Q2	$317K	Buy	+10,600	New	+$289K	﹤0.01%	2793

AllianceBernstein's DOVA Position: Q4 2019 in Review

AllianceBernstein sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 43,400 shares — an estimated $1.21M sold.

AllianceBernstein first reported a position in DOVA in Q2 2018 and held it in 6 quarters. The position peaked at $1.21M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

AllianceBernstein reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
AllianceBernstein sold 43,400 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.21M.
AllianceBernstein first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
AllianceBernstein's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.21M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.